Score Your Stock

US stock · figures in US dollars · scored on full-year results

Cardinal Health Cardinal Health, Inc. Common Stock

CAH · Healthcare · Medical Distribution
Top 29% of scored stocks
OkayTop 29% of scored stocks

Cardinal Health scores 61/100 on fundamentals: in the top 29% of 503 scored S&P 500 stocks. Its strongest area is Cash & Dividends (75/100); its weakest is Price Fairness (33/100).

Best
Cash 75
Risk 75
Weakest
Price 33

An expensively priced stock, but price fairness needs attention.

What looks good
What to watch
Mkt capUS$ 58.1b#213 of 503 in the S&P 500EPSUS$ 7.23P/E34.1×✗ vs sector median 29.6×P/Bn/m (negative equity)Div yield1%Bottom 36% in the S&P 50052w range · 88% of range180.45259.84
as of 31 Oct 2026

Nearby peers

Ranks #19 of 60 in Healthcare by score

#1Universal Health Services79#17West Pharmaceutical Services63#18Medtronic62
#19Cardinal Health61
#20Idexx Laboratories61#21McKesson59

One-Minute Summary

Why Cardinal Health scores 61

An expensively priced stock, but price fairness needs attention.

What looks good
What to watch

Business Strength

50
Why 50?
Pillar score: (0 + 1 + 2 + 0 + 2) = 5 of 10 points → 50
Return on Equity (ROE)n/m (negative equity)Weak4-Year Revenue Growth+7%/yrOkay4-Year Profit Growth+73%/yrStrongNet Profit Margin1%WeakQuarterly Momentum+14%Strong
Show 3 charts

Net Profit & Equity, with ROE

Net Profit ↑ +419.4%Equity → +2.5%
Net ProfitEquityROE %
330m852m1.6b1.7b-3.0b-3.2b-2.8b-2.9b2023202420252026

Revenue & Net Profit, with Net Margin

Revenue ↑ +24%Net Profit ↑ +419.4%Net Margin % 0.7%
RevenueNet ProfitNet Margin %
205.0b226.8b222.6b254.2b330m852m1.6b1.7b20232024202520260.2%0.4%0.7%0.7%

Sales grew about 24% over 4 years: customers keep spending more with this company.

Profit climbed about 419.4% over 4 years: the business keeps more money as it grows.

Recent Quarters: Revenue & Net Profit (the last 8 quarters, scored)

Revenue ↑ +21.8%Net Profit ↓ -4.3%Net Margin % 0.6%
RevenueNet ProfitNet Margin %
52.3b55.3b54.9b60.2b64.0b65.6b60.9b63.7b416m400m506m239m450m467m399m398mQ3'24Q4'24Q1'25Q2'25Q3'25Q4'25Q1'26Q2'260.8%0.7%0.9%0.4%0.7%0.7%0.7%0.6%
▲▲▲▬▲▲▼▲

Sales grew about 21.8% over the last 8 quarters: customers keep spending more with this company.

Profit has moved sideways over the last 8 quarters.

Why 67?
Pillar score: (2 + 0 + 2) = 4 of 6 points → 67
Debt-to-Equity-3.1×StrongCurrent Ratio0.9×WeakInterest Coverage7.3×Strong
Show 2 charts

Debt vs Equity, with D/E ratio

Total Debt ↑ +89%Equity → +2.5%
Total DebtEquityD/E
4.7b5.1b8.5b8.9b-3.0b-3.2b-2.8b-2.9b2023202420252026

Borrowings grew about 89% over 4 years: watch this; rising debt adds pressure in bad times.

Short-term assets vs bills, with Current Ratio

Current Assets ↑ +14.9%Current Liabilities ↑ +30.1%Current Ratio 0.9×
Current AssetsCurrent LiabilitiesCurrent Ratio
33.7b34.9b36.4b38.8b33.7b35.6b38.9b43.9b20232024202520261×1×0.9×0.9×
Why 75?
Pillar score: (0 + 2 + 2 + 2) = 6 of 8 points → 75
Dividend Quality1%Weak
Payout ratio: 29%
Operating Cash FlowPositive & growingStrongFree Cash FlowPositive & growingStrongCash & Cash EquivalentsGrowing & covers near-term debtStrong
Show 3 charts

Operating vs Free Cash Flow

Operating CF ↑ +81.9%Free CF ↑ +91.5%
Operating CFFree CF
2.8b3.8b2.4b5.2b2.4b3.3b1.9b4.5b2023202420252026

The business generates real cash, and more of it each year: a very healthy sign.

Cash vs Total Debt

Cash ↑ +19.1%Short-Term Debt ↑ +137.6%Total Debt ↑ +89%
CashShort-Term DebtTotal Debt
4.1b5.1b3.9b4.9b792m434m550m1.9b4.7b5.1b8.5b8.9b2023202420252026

Dividends per Share, with Yield

DPS (cents) → +2.8%Yield % 0.8%
DPS (cents)Yield %
49.649.649.650.150.650.651.151.151.1198.9150.3202.4204.420232024202520262.8%1.6%1.6%0.8%

Dividends were cut during this period: payouts here are not guaranteed pocket money.

Why 33?
Pillar score: (0 + 0 + 2) = 2 of 6 points → 33
P/E Ratio34.1×WeakP/B Ration/m (negative equity)WeakPEG Ratio0.5Strong
Show chart

Share Price: Weekly Closes (not part of the score)

US$ 254.06US$ 218.44US$ 182.83Oct '25Feb '26Jun '26Oct '26

The share price is up about 32.5% over the past year.

Why 75?
Pillar score: (2 + 0 + 2 + 2 + 1 + 2) = 9 of 12 points → 75
Earnings ConsistencySteadyStrongDebt Trend (4yr)RisingWeakShare Count Trend (4yr)-2%/yrStrongInventory vs Sales (4yr)-5.1 pp/yr vs salesStrongAsset Turnover Trend (4yr)-6.2%OkayQuarterly Consistency1 of 4 quarters downStrong
Show chart

Revenue vs Inventory, with Inventory % of Revenue

Revenue ↑ +24%Inventory ↑ +7.3%Inv. % of Rev. 6.8%
RevenueInventoryInv. % of Rev.
205.0b226.8b222.6b254.2b16.1b15.0b16.8b17.3b20232024202520267.9%6.6%7.6%6.8%
Ranks #19 of 60 in Healthcare by score

Sector peers

#1Universal Health Services79#17West Pharmaceutical Services63#18Medtronic62
#19Cardinal Health (you)61
#20Idexx Laboratories61#21McKesson59

Full Financial History

Every reported figure behind the score, year by year. Download it, or check it against the company's own annual report.

Financial YearRevenueNet ProfitOperating Cash FlowFree Cash FlowCapExCashTotal DebtShort-Term DebtEquityCurrent AssetsCurrent LiabilitiesTotal AssetsTotal LiabilitiesInventoryDividendsReturn on Equity (ROE)Net Profit MarginDebt-to-EquityCurrent RatioInterest CoverageDividend Payout RatioDiv yieldP/E RatioP/B RatioPEG Ratio
2026US$ 254.2bUS$ 1.7bUS$ 5.2bUS$ 4.5bUS$ -649.0mUS$ 4.9bUS$ 8.9bUS$ 1.9bUS$ -2.9bUS$ 38.8bUS$ 43.9bUS$ 57.3bUS$ 60.0bUS$ 17.3bUS$ 204.4m-59%1%-3.1×0.9×7.3×29%1%32.4×-19.3×0.4
2025US$ 222.6bUS$ 1.6bUS$ 2.4bUS$ 1.9bUS$ -547.0mUS$ 3.9bUS$ 8.5bUS$ 550.0mUS$ -2.8bUS$ 36.4bUS$ 38.9bUS$ 53.1bUS$ 55.8bUS$ 16.8bUS$ 202.4m-56%1%-3.1×0.9×10.8×32%1%24.9×-14.0×-
2024US$ 226.8bUS$ 852.0mUS$ 3.8bUS$ 3.3bUS$ -511.0mUS$ 5.1bUS$ 5.1bUS$ 434.0mUS$ -3.2bUS$ 34.9bUS$ 35.6bUS$ 45.1bUS$ 48.3bUS$ 15.0bUS$ 150.3m-27%0%-1.6×1.0×24.6×59%2%27.2×-7.2×-
2023US$ 205.0bUS$ 330.0mUS$ 2.8bUS$ 2.4bUS$ -481.0mUS$ 4.1bUS$ 4.7bUS$ 792.0mUS$ -3.0bUS$ 33.7bUS$ 33.7bUS$ 43.3bUS$ 46.3bUS$ 16.1bUS$ 198.9m-11%0%-1.6×1.0×8.9×159%2%68.5×-7.6×-